Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Maria Lukács KrogagerKristian KragholmJesper Qvist ThomassenPeter SøgaardBasil S LewisSven WassmannIris BaumgartnerClaudio CeconiThomas Andersen SchmidtJuan-Carlos KaskiHeinz DrexelAnne Grete SembStefan AgewallAlexander NiessnerGianluigi SavareseKeld Per KjeldsenClaudio BorghiJuan TamargoChristian Torp-PedersenPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Hypokalaemia is common in patients with cardiovascular disease. In this review, we emphasize the importance of tight potassium regulation in patients with cardiovascular disease based on findings from observational studies. To enhance the understanding, we also describe the mechanisms of potassium homeostasis maintenance, the most common causes of hypokalaemia and present strategies for monitoring and management of low potassium levels. We propose elevation of potassium in asymptomatic patients with lower normal concentrations and concurrent cardiovascular disease. These proposals are intended to assist clinicians until more evidence is available.